Task: Answer the MCQ question.
Query: Which compound exhibits a -6.053% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] CCCNC(=O)c1cc(S(=O)(=O)N2CCc3ccccc32)ccc1F
[b] Cc1nc2ccc(S(=O)(=O)N(C)CC(=O)Nc3ccccc3F)cc2s1
Answer: a. CCCNC(=O)c1cc(S(=O)(=O)N2CCc3ccccc32)ccc1F
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCNC(=O)c1cc(S(=O)(=O)N2CCc3ccccc32)ccc1F
CCCNC(=O)c1cc(S(=O)(=O)N2CCc3ccccc32)ccc1F
5-(2,3-dihydroindol-1-ylsulfonyl)-2-fluoro-N-propylbenzamide